Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Cancer of Ovary

1,2,3,4-tetrahydroquinoline has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abuskhuna, S; Benbrook, DM; Bhandari, D; Bunce, RA; Darrell Berlin, K; Gnanasekaran, KK; Mashayekhi, M; Pouland, T; Zhou, DH	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Cancer of Ovary

Article	Year
Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells. Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1 Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Quinolines; Structure-Activity Relationship; Thiones; Urea	2020

Article

Year

Tetrahydroquinoline units in flexible heteroarotinoids (Flex-Hets) convey anti-cancer properties in A2780 ovarian cancer cells.

Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Chromans; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Quinolines; Structure-Activity Relationship; Thiones; Urea

2020